StockWatch
·

TORRENT PHARMACEUTICALS LTD. Q3 FY25 Results

TORNTPHARMQ3 FY25 Results
Filing
MetricValue (₹ Cr)vs Q2 FY25
Revenue2.8K2.8%
Total Income2.8K1.1%
Expenditure2.2K2.8%
PBT691.004.5%
Net Profit503.0011.0%
OPM14.31%0.05pp
NPM17.70%1.93pp
EPS14.8811.3%
View full financials

Informational and educational content only. Not investment advice.